US drugmakers given 30 days to lower prices

Key Takeaways:

• President Trump signed an executive order to lower prescription drug prices.
• Drugmakers have 30 days to voluntarily reduce medication costs.
• Non-compliance may lead to future limits on government payments for drugs.
• The order aims to make medications more affordable in the U.S.
• The government is increasing pressure on the pharmaceutical industry.

President Signs Executive Order to Lower Drug Prices

President Donald Trump signed an executive order on Monday setting a 30-day deadline for drugmakers to electively reduce the cost of prescription drugs in the United States. This action reflects the administration’s effort to make medications more affordable for Americans.

30-Day Deadline for Pharmaceutical Companies

The executive order mandates that pharmaceutical companies have 30 days to voluntarily lower their prescription drug prices. This timeframe is designed to prompt immediate action from drugmakers in addressing high medication costs.

Potential Limits on Government Payments

Should drugmakers fail to comply with the executive order, they may face new limits down the road over what the government will pay for prescription drugs. This potential for future restrictions serves as a significant incentive for companies to adjust their pricing strategies promptly.